• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION JETSTREAM XC ATHERECTOMY CATHETER; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION JETSTREAM XC ATHERECTOMY CATHETER; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Model Number 45007
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vascular Dissection (3160)
Event Date 08/23/2018
Event Type  Injury  
Event Description
(b)(6) study.It was reported a dissection occurred.On (b)(6) 2018 - the index procedure was performed to treat a 71% stenosed target lesion with a reference vessel diameter of 5.0 mm, length of 50 mm and classified as a tasc ii, located in the left mid superficial femoral artery (sfa).The target lesion was successfully treated with the use of a jetstream xc 2.1/3.0 mm and a jetstream xc 2.4/3.4 catheter.It was noted that a grade b dissection occurred after using the jetstream catheters prior to ballooning and stenting.Intervention was performed to treat the event.Post treatment, percutaneous transluminal balloon angioplasty (pta) was performed, with 0% final residual stenosis.The event was considered to be resolved.
 
Event Description
(b)(6) study.It was reported a dissection occurred.(b)(6) 2018 - the index procedure was performed to treat a 71% stenosed target lesion with a reference vessel diameter of 5.0 mm, length of 50 mm and classified as a tasc ii, located in the left mid superficial femoral artery (sfa).The target lesion was successfully treated with the use of a jetstream xc 2.1/3.0 mm and a jetstream xc 2.4/3.4 catheter.It was noted that a grade b dissection occurred after using the jetstream catheters prior to ballooning and stenting.Intervention was performed to treat the event.Post treatment, percutaneous transluminal balloon angioplasty (pta) was performed, with 0% final residual stenosis.The event was considered to be resolved.It was further reported that an entirely specific stenting procedure was performed to treat the grade b dissection which occurred after the use of the jetstream devices, before further balloon and stenting occurred.
 
Event Description
Jetstream (b)(6) study.It was reported a dissection occurred.On (b)(6) 2018 - the index procedure was performed to treat a 71% stenosed target lesion with a reference vessel diameter of 5.0 mm, length of 50 mm and classified as a tasc ii, located in the left mid superficial femoral artery (sfa).The target lesion was successfully treated with the use of a jetstream xc 2.1/3.0 mm and a jetstream xc 2.4/3.4 catheter.It was noted that a grade b dissection occurred after using the jetstream catheters prior to ballooning and stenting.Intervention was performed to treat the event.Post treatment, percutaneous transluminal balloon angioplasty (pta) was performed, with 0% final residual stenosis.The event was considered to be resolved.It was further reported that an entirely specific stenting procedure was performed to treat the grade b dissection which occurred after the use of the jetstream devices, before further balloon and stenting occurred.Device evaluated by mfr: the device and the catheter shaft were checked for damage.The device showed no damage.Functional testing revealed the device functioned as designed with no errors or issues.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JETSTREAM XC ATHERECTOMY CATHETER
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key7890187
MDR Text Key120754977
Report Number2134265-2018-61125
Device Sequence Number1
Product Code MCW
Combination Product (y/n)N
PMA/PMN Number
K130637
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 11/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/19/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/04/2019
Device Model Number45007
Device Catalogue Number45007
Device Lot Number0021336425
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/05/2018
Date Manufacturer Received11/08/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-